Biora Therapeutics, Inc. (BIOR)

NASDAQ: BIOR · IEX Real-Time Price · USD

0.660

-0.041 (-5.89%)

At close: Jul 19, 2024, 12:00 AM

0.685

+0.025 (3.77%)

Pre-market: Jul 22, 2024, 8:44 AM EDT

Biora Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-110.86	-124.12	-38.16	-247.41	-192.8	-228.83	Upgrade
Depreciation & Amortization	0.51	0.56	0.91	1.44	1.44	4.68	Upgrade
Share-Based Compensation	15.63	16.48	7.8	11.96	8.24	2.38	Upgrade
Other Operating Activities	45.82	58.59	-34.97	66.53	17.1	34.86	Upgrade
Operating Cash Flow	-48.9	-48.5	-64.42	-167.49	-165.74	-106.12	Upgrade
Capital Expenditures	-0.08	-0.09	-0.79	-0.86	-3.87	-3.73	Upgrade
Acquisitions	3	0	0	0	0	0	Upgrade
Change in Investments	0	0	0	0	0	20.25	Upgrade
Other Investing Activities	2.54	2.54	-	-0.39	-1.07	-	Upgrade
Investing Cash Flow	5.45	2.44	-0.79	-1.24	-4.94	16.53	Upgrade
Dividends Paid	0	0	0	0	0	-4.5	Upgrade
Share Issuance / Repurchase	16.05	26.14	12.43	172.22	116.44	0.55	Upgrade
Debt Issued / Paid	10.55	7.74	-5.13	-5.39	92.23	-1.28	Upgrade
Other Financing Activities	-2.8	-3.09	-	-1.78	21.06	78.86	Upgrade
Financing Cash Flow	23.8	30.78	7.3	165.05	229.72	73.64	Upgrade
Net Cash Flow	-19.64	-15.28	-57.91	-3.68	59.03	-15.96	Upgrade
Free Cash Flow	-48.98	-48.59	-65.21	-168.34	-169.62	-109.85	Upgrade
Free Cash Flow Margin	-9003.31%	-1214775.00%	-21380.00%	-13499.68%	-104700.62%	-76.29%	Upgrade
Free Cash Flow Per Share	-1.67	-3.08	-8.54	-43.77	-154.12	-562.44	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).